By Pat Rizzuto
May 21 — U.S. and European officials negotiating the Transatlantic Trade and Investment Partnership (TTIP) agreement must ensure regulations on both sides of the Atlantic are based on the actual risks products pose, not just hazards they might cause, a senior trade adviser said.
If pesticides were regulated solely on their hazards, the benefits they pose by killing poisonous plants, for example, would be eliminated. There is no reason to eliminate a risk-based approach to regulations, Douglas Nelson, senior adviser for trade, intellectual property and strategic issues for CropLife America, said.
He spoke during a stakeholder presentation session held during the fifth round of TTIP negotiations, which continue through May 23.
The European Union's regulation on plant protection products, (EC) No. 1107/2009, violates the World Trade Organization's agreement on Sanitary and Phytosanitary (SPS) measures, Nelson said.
Under that WTO agreement, regulations that countries adopt to protect the public's health must be based on an appropriate assessment of the actual risks involved.
When the endocrine disruption provisions of the EU's plant protection regulation go into effect, the EU would no longer be using a risk-based approach, Nelson said.
Pesticides would be regulated based solely on their hazard and their potential to be endocrine disruptors rather than on a risk assessment that would determine whether people or the environment would be harmed following exposure to those compounds, he said.
That hazard-based approach could result in commodities valued at 65 billion euros ($88.96 billion) being prohibited from the European market, Nelson said. That total would include 4 billion euros worth of U.S. crops being barred from the European Union and 11 billion euros ($15.06 billion) worth of crops from Brazil, he said.
Nelson referred to conclusions in a report CropLife International released in February.
Marie D'Avignon, government relations manager for the Apparel & Footwear Association, urged European and U.S. negotiators to work toward regulatory approaches that harmonize the different ways chemicals are regulated in Europe and within the U.S.
The Toxic Substances Control Act hasn't been updated in nearly 40 years, D'Avignon said.
State governments are responding by developing their own regulations for chemicals, she said.
It is difficult for companies to enter the U.S. market because there isn't a consistent federal approach to regulating chemicals, D'Avignon said. Instead, companies must comply with regulations by states ranging from Alaska to Maine, she said.
Chemicals must be regulated consistently throughout the European Union, she said. Denmark has banned four phthalates, D'Avignon said. She referred to that country's regulation of di (2-ethylhexyl) phthalate (DEHP), di-n-butyl phthalate (DBP), butylbenzyl phthalate (BBP), and diisobutyl phthalate (DIBP).
Chemical management must be centralized at the federal level within the U.S. and consistent within the European Union, she said.
States must retain the right to protect their residents by adopting chemical legislation and regulations, countered Vermont state Sen. Virginia Lyons (D), representing the Vermont Commission on International Trade. The Vermont Legislature established the commission to protect state jobs and businesses and state sovereignty from negative effects of trade agreements.
States such as California, Maine, Vermont and Washington are leading the way by developing innovative laws and regulations that encourage public health and environmental protection and thereby save money otherwise lost due to illness stemming from environmental exposures, Lyons said.
“States must be heard as TTIP is discussed,” she said.
To contact the reporter on this story: Pat Rizzuto in Washington at email@example.com
To contact the editor responsible for this story: Larry Pearl at firstname.lastname@example.org
CropLife International's report, “Potential Trade Effects on World Agricultural Exporters of European Union Regulations on Endocrine Disruptors,” is available at http://op.bna.com/env.nsf/r?Open=prio-9kbqaj.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)